Opticlik


Combined with:

Lantus

Indications and Reactions:

Role Indications Reactions
Secondary
Diabetes Mellitus Non-insulin-dependent 39.1%
Type 2 Diabetes Mellitus 26.7%
Diabetes Mellitus Insulin-dependent 12.0%
Diabetes Mellitus 11.1%
Type 1 Diabetes Mellitus 8.9%
Blood Glucose Abnormal 0.2%
Blood Glucose Increased 0.2%
Cardiac Disorder 0.2%
Diplopia 0.2%
Glycosylated Haemoglobin Increased 0.2%
Nasopharyngitis 0.2%
Rheumatoid Arthritis 0.2%
Arthritis 0.1%
Hypertension 0.1%
Insulin-requiring Type Ii Diabetes Mellitus 0.1%
Lymphoma 0.1%
Renal Disorder 0.1%
Hyperglycaemia 38.9%
Hypoglycaemia 13.5%
Blood Glucose Increased 7.6%
Wrong Drug Administered 6.2%
Medication Error 5.8%
Blood Glucose Decreased 4.0%
Overdose 4.0%
Drug Ineffective 2.5%
Nausea 2.2%
Injection Site Extravasation 1.8%
Nervousness 1.8%
Vision Blurred 1.8%
Visual Disturbance 1.8%
Hypoglycaemic Unconsciousness 1.5%
Somnolence 1.5%
Hypoglycaemic Seizure 1.1%
Injection Site Bruising 1.1%
Tremor 1.1%
Vomiting 1.1%
Feeling Abnormal 0.7%
Concomitant
Diabetes Mellitus Non-insulin-dependent 100.0%
Blood Glucose Increased 50.0%
No Adverse Effect 50.0%

Drug Data